Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Obesema 1.7 mg injection (by Alkem) is a weekly GLP-1 receptor agonist primarily used for chronic weight management and type 2 diabetes, acting as a sub-cutaneous injection. Key tags include: Semaglutide, obesity medication, weekly weight loss pen, type 2 diabetes management, and chronic weight management
| Active Ingredients | Semaglutide 1.7 mg |
| Category | GLP-1 receptor agonist |
| Storage Requirement | 2–8°C |